GE Healthcare Technologies (GEHC) in our Pivotal Point Check: Medical Technology Giant with Strong Q2 Figures and a Record Order Backlog of $23.9 Billion!
Reading Time: 2 minutes
Strong Q2 financials: Revenue ($5.30 billion) and adjusted earnings per share ($1.13) significantly exceed analyst expectations. Record order backlog: Thanks to high demand in pharmaceutical diagnostics and imaging, the order book rises to $23.9 billion. Confirmed annual outlook: Management maintains its forecast of organic revenue growth of 3-4%. GE HealthCare Technologies, a leading global provider of medical technology, pharmaceutical diagnostics, and digital health solutions, created a significant boost on the stock market on...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
